Closed
3.33 2.78
24h
Min
3.19
Max
3.34
Income | 7.2M -13M |
---|---|
Sales | 235K 1.6M |
EPS | -0.1 |
Profit margin | -796.188 |
Employees | 44 |
EBITDA | 7.2M -12M |
Recommendations | Buy |
---|---|
12 Months Forecast | +49.7% upside |
Next Earnings | 1 May 2025 |
---|
Market Cap | -28M 615M |
---|---|
Previous open | 0.55 |
Previous close | 3.33 |
By Trading Central
Confidence
Strong Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 5 USD 49.7%
High 5 USD
Low 5 USD
Based on 1 Wall Street analysts offering 12 month price targets forArbutus Biopharma Corp - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$